Fund I is currently in its pre-marketing phase with first close targeted for Q1 2027. The grid below previews the structure of the portfolio we are building — a concentrated set of ~20 early-stage European HealthTech companies across three focus verticals.
First investments will be announced following Fund I's first close. Portfolio updates and news of new investments will be published on the Insights page as they happen.
Beyond the Fund I portfolio, the founding partners bring direct engagement with hundreds of European HealthTech companies through past engagements and institutional advisory mandates.
Figures reflect total lifetime capital raised by companies personally supported by the Hygeia Ventures founding partners through institutional roles — not capital deployed by Hygeia Ventures Fund I, and not solely attributable to partner involvement.